<PubmedArticle>
 <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
  <PMID Version="1">
   30416724
  </PMID>
  <DateRevised>
   <Year>
    2022
   </Year>
   <Month>
    03
   </Month>
   <Day>
    30
   </Day>
  </DateRevised>
  <Article PubModel="Electronic-eCollection">
   <Journal>
    <ISSN IssnType="Print">
     2049-0801
    </ISSN>
    <JournalIssue CitedMedium="Print">
     <Volume>
      36
     </Volume>
     <PubDate>
      <Year>
       2018
      </Year>
      <Month>
       Dec
      </Month>
     </PubDate>
    </JournalIssue>
    <Title>
     Annals of medicine and surgery (2012)
    </Title>
    <ISOAbbreviation>
     Ann Med Surg (Lond)
    </ISOAbbreviation>
   </Journal>
   <ArticleTitle>
    Plasma d-dimer level correlated with advanced breast carcinoma in female patients.
   </ArticleTitle>
   <Pagination>
    <MedlinePgn>
     75-78
    </MedlinePgn>
   </Pagination>
   <ELocationID EIdType="doi" ValidYN="Y">
    10.1016/j.amsu.2018.10.025
   </ELocationID>
   <Abstract>
    <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">
     Advanced breast cancer is a common disease among female in the world. There is a correlation between cancer and hyper coagulation. In a cancer state, there is an increase in the level of cross-linked fibrin degradation product (d-dimer)which indicates systemic activation of fibrinolysis and hemostasis. So, there is a relation between increase d-dimer value and advanced breast disease.
    </AbstractText>
    <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">
     To confirm the relation between increase d-dimer levels and advanced breast carcinoma in female patients.
    </AbstractText>
    <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">
     A prospective study (cohort study) done in Baghdad teaching hospital (department of surgery) from Jan 2014 to Jan 2016. Seventy patients were categorized intotwo equal groups, group 1 with breast carcinoma, group 2 with benign breast tumor. Plasma d-dimer levels compared for each group, and in relation to (tumor size, stage, grade, lympho-vascular invasion, and lymph nodes involvement).
    </AbstractText>
    <AbstractText Label="RESULTS" NlmCategory="RESULTS">
     D-dimer level was normal in group two (&lt;0.25) mg/l and high in group one in other words, d-dimer level was increasing in advanced breast carcinoma group with enlarge tumor size, high stage, grade, lympho-vascular invasion and lymph nodes involvement.
    </AbstractText>
    <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">
     Plasma d-dimer levels was good prognostic factor in breast carcinoma specially in advanced breast carcinoma and its considered factor clinical stage progression lympho-vascular invasion and metastasis.
    </AbstractText>
   </Abstract>
   <AuthorList CompleteYN="Y">
    <Author ValidYN="Y">
     <LastName>
      Ghadhban
     </LastName>
     <ForeName>
      Basim Rassam
     </ForeName>
     <Initials>
      BR
     </Initials>
     <AffiliationInfo>
      <Affiliation>
       College of Medicine, Baghdad University, Baghdad Teaching Hospital/ Department of Surgery, Iraq.
      </Affiliation>
     </AffiliationInfo>
    </Author>
   </AuthorList>
   <Language>
    eng
   </Language>
   <PublicationTypeList>
    <PublicationType UI="D016428">
     Journal Article
    </PublicationType>
   </PublicationTypeList>
   <ArticleDate DateType="Electronic">
    <Year>
     2018
    </Year>
    <Month>
     10
    </Month>
    <Day>
     26
    </Day>
   </ArticleDate>
  </Article>
  <MedlineJournalInfo>
   <Country>
    England
   </Country>
   <MedlineTA>
    Ann Med Surg (Lond)
   </MedlineTA>
   <NlmUniqueID>
    101616869
   </NlmUniqueID>
   <ISSNLinking>
    2049-0801
   </ISSNLinking>
  </MedlineJournalInfo>
  <KeywordList Owner="NOTNLM">
   <Keyword MajorTopicYN="N">
    Advanced breast cancer
   </Keyword>
   <Keyword MajorTopicYN="N">
    D-dimer level
   </Keyword>
   <Keyword MajorTopicYN="N">
    Hyper coagulation
   </Keyword>
   <Keyword MajorTopicYN="N">
    Metastasis
   </Keyword>
  </KeywordList>
 </MedlineCitation>
 <PubmedData>
  <History>
   <PubMedPubDate PubStatus="received">
    <Year>
     2018
    </Year>
    <Month>
     09
    </Month>
    <Day>
     14
    </Day>
   </PubMedPubDate>
   <PubMedPubDate PubStatus="revised">
    <Year>
     2018
    </Year>
    <Month>
     10
    </Month>
    <Day>
     16
    </Day>
   </PubMedPubDate>
   <PubMedPubDate PubStatus="accepted">
    <Year>
     2018
    </Year>
    <Month>
     10
    </Month>
    <Day>
     18
    </Day>
   </PubMedPubDate>
   <PubMedPubDate PubStatus="entrez">
    <Year>
     2018
    </Year>
    <Month>
     11
    </Month>
    <Day>
     13
    </Day>
    <Hour>
     6
    </Hour>
    <Minute>
     0
    </Minute>
   </PubMedPubDate>
   <PubMedPubDate PubStatus="pubmed">
    <Year>
     2018
    </Year>
    <Month>
     11
    </Month>
    <Day>
     13
    </Day>
    <Hour>
     6
    </Hour>
    <Minute>
     0
    </Minute>
   </PubMedPubDate>
   <PubMedPubDate PubStatus="medline">
    <Year>
     2018
    </Year>
    <Month>
     11
    </Month>
    <Day>
     13
    </Day>
    <Hour>
     6
    </Hour>
    <Minute>
     1
    </Minute>
   </PubMedPubDate>
  </History>
  <PublicationStatus>
   epublish
  </PublicationStatus>
  <ArticleIdList>
   <ArticleId IdType="pubmed">
    30416724
   </ArticleId>
   <ArticleId IdType="doi">
    10.1016/j.amsu.2018.10.025
   </ArticleId>
   <ArticleId IdType="pii">
    S2049-0801(18)30234-6
   </ArticleId>
   <ArticleId IdType="pmc">
    PMC6215958
   </ArticleId>
  </ArticleIdList>
  <ReferenceList>
   <Reference>
    <Citation>
     Eur J Surg Oncol. 2013 Sep;39(9):951-6
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      23810331
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     JAMA. 2004 Sep 1;292(9):1064-73
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      15339900
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Haematologica. 2013 Sep;98(9):1476-80
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      23645692
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Cancer Lett. 1999 Nov 1;146(1):61-6
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      10656610
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      15761078
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Asian Pac J Cancer Prev. 2014;15(1):117-22
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      24528011
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Am J Pathol. 1995 May;146(5):1029-39
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      7538264
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Breast Cancer Res Treat. 2008 Feb;107(3):309-30
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      17377838
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      25559415
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Dig Liver Dis. 2001 Oct;33(7):546-50
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      11816542
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Haemostasis. 1997 May-Jun;27(3):112-8
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      9306127
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Br J Cancer. 2002 Feb 1;86(3):389-95
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      11875705
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Magy Onkol. 2013 Mar;57(1):56-62
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      23573523
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     J Clin Oncol. 2000 Feb;18(3):600-8
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      10653875
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     J Clin Pathol. 2010 Sep;63(9):818-22
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      20671046
     </ArticleId>
    </ArticleIdList>
   </Reference>
   <Reference>
    <Citation>
     Semin Thromb Hemost. 1999;25(2):173-82
    </Citation>
    <ArticleIdList>
     <ArticleId IdType="pubmed">
      10357085
     </ArticleId>
    </ArticleIdList>
   </Reference>
  </ReferenceList>
 </PubmedData>
</PubmedArticle>
